Trial Profile
Dapagliflozin on Cholesterol Metabolism in DM2: Dissecting Its Effect on Dyslipidemia by Using Stable Isotope Based Cholesterol and Glucose Fluxes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2022
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Rosuvastatin
- Indications Hypercholesterolaemia; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DICE
- 08 May 2018 Status changed from recruiting to completed.
- 14 Mar 2017 New trial record